Overall survival and progression-free survival of patients with diffuse large B-cell lymphoma.

(A,B) Patients with high nm23-H1 (≥ 12.01 ng/mL; n = 187) had a worse prognosis than patients with low nm23-H1 (< 12.01 ng/mL; n = 127). (C,D) Patients with high nm23-H1 (≥ 80 ng/mL; n = 42) had a worse prognosis than patients with low nm23-H1 (< 80 ng/mL; n = 272).